Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-001449
Filing Date
2025-05-05
Accepted
2025-05-05 16:19:43
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3696
  Complete submission text file 0000905148-25-001449.txt   5134
Mailing Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BLVD. #110 MALVERN PA 19355
Business Address
Sussman Joel F. (Reporting) CIK: 0001774297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 25913264